Inactive Instrument

Other languages Biosyent Inc. Toronto S.E.

Equities

RX

CA0906901081

Other languages

BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 16
BioSyent Inc Declares Second Quarter 2024 Dividend, Payable June 15, 2024	May. 16
FeraMAX® est la marque de supplément de fer que les pharmaciens et les médecins au Canada recommandent le plus souvent depuis neuf années consécutives	Apr. 03
BioSyent To Present At LD Micro New York Investor Conference	Apr. 01
BioSyent Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13
BioSyent Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 13
BioSyent Inc. Seeks Acquisitions	Mar. 12
BioSyent Inc. Declares First Quarter 2024 Dividend, Payable on March 15, 2024	Feb. 06
BioSyent Inc. (TSXV:RX) announces an Equity Buyback for 650,000 shares, representing 5.53% of its issued share capital.	Dec. 13
BioSyent Inc. authorizes a Buyback Plan.	Dec. 12
Biosyent Reports Q3 2023 Results	Nov. 16
BioSyent Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16
BioSyent Inc. Declares Fourth Quarter 2023 Dividend, Payable on December 15, 2023	Nov. 15
BioSyent Posts Higher Q2 Net Income, Revenue YOY	23-08-22
BioSyent Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22
BioSyent Inc. Declares Third Quarter 2023 Dividend, Payable on September 15, 2023	23-08-22
BioSyent Launches Inofolic for Women with Polycystic Ovary Syndrome	23-08-08
BioSyent lance Inofolic® pour les femmes atteintes du syndrome des ovaires polykystiques (SOPK)	23-08-08
BioSyent Posts Lower Q1 Net Income	23-05-26
BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biosyent Inc. Toronto S.E.

Equities

RX

CA0906901081

Other languages

Filters